yttrium radioisotopes has been researched along with Cancer of Gastrointestinal Tract in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, CJ; Erali, RA; Howerton, R; Mangieri, CW; Shen, P; Strode, MA; Valenzuela, CD | 1 |
| Chapiro, J; Do Minh, D; Gebauer, B; Geschwind, JF; Gorodetski, B; Huang, Q; Lin, M; Liu, C; Savic, LJ; Schlachter, T; Smolka, S; Wainstejn, D | 1 |
| Feliu, J; Minaya-Bravo, A; Prieto, I; Rodriguez-Salas, N; Viñal, D | 1 |
| Bergsland, EK; Fidelman, N; Hawkins, RA; Kelley, RK; Kerlan, RK; Ko, AH; Kohi, MP; Kolli, KP; Korn, WM; Luan, J; McWhirter, RM; Taylor, AG; Venook, AP | 1 |
| Diehl, SJ; Dinter, D; Hohenberger, P; Pink, D; Rathmann, N; Schoenberg, SO; Schütte, J | 1 |
| Eriksson, B; Garske, U; Granberg, D; Kindmark, H; Nyman, R; Oberg, K; Welin, S | 1 |
| Ellis, S; Hahl, M; Martin, RC; McMasters, K; Scoggins, CR; Tatum, C; Whitney, R | 1 |
| Buscombe, JR; Cwikla, JB; Jeziorski, KG; Mikolajczak, R; Nasierowska-Guttmejer, A; Pawlak, D; Sankowski, A; Seklecka, N; Stepien, K; Walecki, J | 1 |
| de Herder, WW; Krenning, EP; Kwekkeboom, DJ | 1 |
| Forrer, F; Giovacchini, G; Müller-Brand, J; Nicolas, G | 1 |
| Bertagna, F; Bettinsoli, G; Biasiotto, G; Bosio, G; Dognini, L; Ferrari, C; Ferrari, V; Franco, F; Giubbini, R; Migliorati, E; Minari, C; Rodella, C; Savelli, G; Tomassetti, P; Zaniboni, A | 1 |
| Buziak-Bereza, M; Gilis-Januszewska, A; Hubalewska-Dydejczyk, A; Jabrocka-Hybel, A; Krolicki, L; Kunikowska, J; Matyja, M; Mikolajczak, R; Pach, D; Sowa-Staszczak, A; Stefanska, A; Tomaszuk, M; Trofimiuk, M | 1 |
| Axworthy, DB; Besh, S; Breitz, H; Chen, KH; Forero-Torres, A; Khazaeli, MB; LoBuglio, AF; Meredith, RF; Percent, I; Shen, S; Sims, RB | 1 |
| de Jong, M; Esser, JP; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R | 1 |
| Bakker, WH; Barone, R; Bouterfa, H; Jamar, F; Krenning, EP; Kvols, LK; Kwekkeboom, DJ; Pauwels, S; Valkema, R | 1 |
| Bockisch, A; Broelsch, CE; Frilling, A; Hofmann, M; Mueller-Brand, J; Saner, F; Weber, F | 1 |
| de Herder, WW; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Teunissen, JJ; Valkema, R | 1 |
| Akabani, G; Augustine, SC; Baranowska-Kortylewicz, J; Colcher, D; Eckblade, M; Harrison, KA; Hawkins, WG; Leichner, PK; Tempero, MA; Wisecarver, J | 1 |
| Anderson, J; Augustine, S; Baranowska-Kortylewicz, J; Colcher, D; Harrison, K; Leichner, P; Schlom, J; Tempero, M; Wisecarver, J | 1 |
| Anderson, P; Bradwell, AR; Chapman, CE; Dykes, PW; Vaughan, AT | 1 |
5 review(s) available for yttrium radioisotopes and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies.
Topics: Brachytherapy; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Yttrium Radioisotopes | 2022 |
Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
Topics: Animals; Antineoplastic Agents; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes | 2011 |
Targeted radiotherapy with radiolabeled somatostatin analogs.
Topics: Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Molecular Targeted Therapy; Neuroendocrine Tumors; Pancreatic Neoplasms; Patient Selection; Radiation Injuries; Radioisotopes; Radionuclide Imaging; Radiotherapy; Somatostatin; Yttrium Radioisotopes | 2011 |
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Topics: Animals; Carcinoma, Neuroendocrine; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Patient Selection; Pentetic Acid; Peptides, Cyclic; Quality of Life; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Peptide; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
Topics: Endocrine Gland Neoplasms; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Lutetium; Octreotide; Sensitivity and Specificity; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2007 |
8 trial(s) available for yttrium radioisotopes and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Feasibility Studies; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Pilot Projects; Prognosis; Prospective Studies; Yttrium Radioisotopes | 2014 |
Radioembolization in patients with progressive gastrointestinal stromal tumor liver metastases undergoing treatment with tyrosine kinase inhibitors.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Chemoradiotherapy; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Liver Neoplasms; Male; Middle Aged; Protein-Tyrosine Kinases; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2015 |
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Disease Progression; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radionuclide Imaging; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2010 |
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotide.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Radionuclide Imaging; Retreatment; Survival Rate; Yttrium Radioisotopes | 2012 |
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Biotin; Clinical Trials as Topic; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Gamma Cameras; Gastrointestinal Neoplasms; Glycoproteins; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Recombinant Fusion Proteins; Rhenium; Streptavidin; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.
Topics: Adult; Aged; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Survival Rate; Yttrium Radioisotopes | 2006 |
Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Yttrium Radioisotopes | 2006 |
High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Biopsy; Dose-Response Relationship, Radiation; Female; Gastrointestinal Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunotoxins; Indium Radioisotopes; Male; Middle Aged; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2000 |
7 other study(ies) available for yttrium radioisotopes and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Effect of preoperative liver-directed therapy prior to hepatic resection.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Failure; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2023 |
Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.
Topics: ADAM17 Protein; Adult; Aged; Biomarkers, Tumor; Chemoembolization, Therapeutic; Epidemiologic Methods; Female; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Selective internal radiation therapy in patients with carcinoid liver metastases.
Topics: Brachytherapy; Carcinoid Tumor; Chemoembolization, Therapeutic; Female; Gastrointestinal Neoplasms; Glass; Hepatic Artery; Humans; Liver Neoplasms; Microspheres; Resins, Synthetic; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
Topics: Adult; Carcinoma, Adenosquamous; Cholangiocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Female; Gastrinoma; Gastrointestinal Neoplasms; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Microspheres; Middle Aged; Radiotherapy; Registries; Sarcoma; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Statistics as Topic; Thyroid Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2011 |
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49.
Topics: Absorption; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Female; Gastrointestinal Neoplasms; Glycoproteins; Half-Life; Humans; Indium Radioisotopes; Liver; Male; Middle Aged; Radioimmunotherapy; Radiotherapy Dosage; Spleen; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 1997 |
Limitations to the killing of tumours using radiolabelled antibodies.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Digestive System; Gastrointestinal Neoplasms; Humans; Iodine Radioisotopes; Radiotherapy Dosage; Yttrium Radioisotopes | 1987 |